Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-005222
Filing Date
2022-01-27
Accepted
2022-01-27 16:41:41
Documents
1
Period of Report
2022-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6073
  Complete submission text file 0001209191-22-005222.txt   7461
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARIBOU BIOSCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Haurwitz Rachel E. (Reporting) CIK: 0001670579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 22563744